88132-60-9

Upstream product

• 88132-50-7 3-carbomethoxy-4-methyl-5-nitrobenzenediazonium fluoroborate 
• 88156-73-4 1-p-toluenesulfonyl-4-carbomethoxy-6-(p-toluenesulfonyloxy)indole 
• 88132-58-5 (Z)-1-p-toluenesulfonyl-4-(2-methoxyvinyl)-6-(p-toluenesulfonyloxy)indole 
• 88132-53-0 3-nitro-4-<2-(dimethylamino)ethenyl>-5-carbomethoxyphenyl p-toluenesulfonate 
• 88132-52-9 3-nitro-4-methyl-5-carbomethoxyphenyl p-toluenesulfonate 
• 88132-54-1 4-carbomethoxy-6-(p-toluenesulfonyloxy)indole 
• 88132-57-4 (Z)-4-(2-methoxyvinyl)-6-(p-toluenesulfonyloxy)indole 
• 88132-55-2 4-(hydroxymethyl)-6-(p-toluenesulfonyloxy)indole 
• 88132-56-3 4-formyl-6-(p-toluenesulfonyloxy)indole 
• 88132-48-3 methyl 5-amino-2-methyl-3-nitrobenzoate 
• 88132-51-8 methyl 5-hydroxy-2-methyl-3-nitrobenzoate 
• 52090-24-1 methyl 2-methyl-3,5-dinitrobenzoate 
• 88132-59-6 (Z)-1-p-toluenesulfonyl-4-<2-(di-n-propylamino)vinyl>-6-(p-toluenesulfonyloxy)indole 

Downstream Products

• 94270-93-6 4-<2-(dipropylamino)ethyl>-6-hydroxyimidole 

Relevant academic research and scientific papers

6-Hydroxy-4-[2-(di-n-propylamino)ethyl]indole: Synthesis and dopaminergic actions

The title compound was proposed to be a biologically active metabolite of a dopaminergic agent, 4-[2-(di-n-propylamino)ethyl]indole. This proposed metabolite was synthesized by a multistep sequence beginning with methyl 3,5-dinitro o-toluate, and involvin